Deep search
Rewards
Search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
U.S.
Local
World
Science
Technology
Entertainment
Business
Sports
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Pharmaceutical Technology
21m
Mesenchymal Stem Cell (MSC) by Cell Energy Life Sciences Group for Lung Injury: Likelihood of Approval
According to GlobalData, Phase II drugs for Lung Injury does not have sufficient historical ... trials by using mesenchymal stem cells to treat patients suffering with advanced stages of AIDS. The ...
Pharmaceutical Technology
47m
AZD-9574 by AstraZeneca for Non-Small Cell Lung Cancer: Likelihood of Approval
AZD-9574 is under clinical development by AstraZeneca and currently in Phase II for Non-Small Cell Lung Cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Takes a dip in Seine River
Teen girl killed at mall
US ends legal fight
Endangered gorilla born
US Independence Day
Colorado monolith removed
NZ tourist killed at CA mall
US to send fighter jets to JP
Sells for record $22M
Bitcoin hits 2-month low
Hippos can get airborne?
Sparkles at holiday BO
Sudo sets a new record
Flight diverted to Buffalo
1 hospitalized after shark bite
MN juror bribery case
Biden speaks w/ Netanyahu
Clinic blockade sentencing
Russia sentences US man
Releases new single
Chinese doping tests probe
Juneteenth shooting charges
Buys Neiman Marcus
July 4th Chicago shooting
Feds to fight invasive fish
Fourth of July heat wave
Boil water advisory lifted
Cleveland officer shot dead
Green fluid leak at airport
DE city renamed after Swift
Full interview in prime time
Ranger hurt, suspect dead
Wins hot dog eating contest
Horses killed on LA freeway
Ukraine’s army retreats
Feedback